Major improvement in thyroid cancer survival of elderly patients in the Nordic countries
European Journal of Endocrinology · 2024
DOI: 10.1093/ejendo/lvae015 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von František Zitrický und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen 30605, Czech Republic. Hauptthemen laut MEDLINE: Thyroid Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Union's Horizon 2020, Jane and Aatos Erkko Foundation, Sigrid Juselius Foundation.
Abstract (Originalsprache)
Objectives
We describe age-specific survival in thyroid cancer (TC) from Denmark, Finland, Norway, and Sweden over a 50-year period.
Design
Population-based survival study.
Methods
Relative 5-year survival data were obtained from the NORDCAN database for the years 1972-2021.
Results
In the first period 1972-1976, 5-year survival in TC in Finland, Norway, and Sweden was 90% or higher, but a strong negative step-wise age gradient was observed, which was worse for men than women. Over time, survival increased, and in the final period, 2017-2021, survival for all women and Danish men up to age 69 years was about 90% or higher and, for men from the other countries, only marginally lower. Even for older women survival reached 80%, for older men somewhat less.
Conclusions
Age disadvantage in TC survival was for the most part corrected over the 50-year period, and the remaining task is to boost survival for the oldest patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen 30605, Czech Republic.
- Department of Otorhinolaryngology- Head and Neck Surgery, Helsinki University Hospital, University of Helsinki, 00029 Helsinki, Finland.
- Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, 00029 Helsinki, Finland.
- Biomedical Center, Charles University Medical School, 32300 Pilsen, Czech Republic.
- Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.
- Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.
ORCID-Profile: Akseli Hemminki, Kari Hemminki
Förderung
- European Union's Horizon 2020
- Jane and Aatos Erkko Foundation
- Sigrid Juselius Foundation
- Finnish Cancer Organizations
- University of Helsinki
- Helsinki University Central Hospital
- Novo Nordisk Foundation
- Päivikki and Sakari Sohlberg Foundation
Zitieren
APA
Zitrický, F., Koskinen, A., Liska, V., Försti, A., Hemminki, A., & Hemminki, K. (2024). Major improvement in thyroid cancer survival of elderly patients in the Nordic countries. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae015
Vancouver
Zitrický F, Koskinen A, Liska V, Försti A, Hemminki A, Hemminki K. Major improvement in thyroid cancer survival of elderly patients in the Nordic countries. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae015
BibTeX
@article{Zitrick2024,
author = {Zitrický, František and Koskinen, Anni and Liska, Vaclav and Försti, Asta and Hemminki, Akseli and Hemminki, Kari},
title = {Major improvement in thyroid cancer survival of elderly patients in the Nordic countries},
journal = {European Journal of Endocrinology},
year = {2024},
doi = {10.1093/ejendo/lvae015}
}
EUVIMED